Citation Impact
Citing Papers
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
2008 StandoutScience
The microbiota regulates type 2 immunity through RORγt + T cells
2015 StandoutScienceNobel
Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer
2010
Complex between Peptostreptococcus magnus Protein L and a Human Antibody Reveals Structural Convergence in the Interaction Modes of Fab Binding Proteins
2001
Functional diversity of helper T lymphocytes
1996 StandoutNature
Phospholipase A2 subclasses in acute respiratory distress syndrome
2009
Myeloid-derived suppressor cells coming of age
2018 Standout
Biology of Secretory Phospholipase A2
2008
A guide to immunometabolism for immunologists
2016 Standout
Differential activation of human basophils by anti‐IgE and formyl‐methionyl‐leucylphenylalanine. Indications for protein kinase C‐dependent and ‐independent activation pathways
1991
Cryopyrin activates the inflammasome in response to toxins and ATP
2006 StandoutNature
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
2006
Phospholipase A2s: Developing drug targets for atherosclerosis
2010
Age-dependent expression of the erythropoietin gene in rat liver and kidneys.
1992 StandoutNobel
Extracellular phospholipases in atherosclerosis
2010
High density associated enzymes: their role in vascular biology
1998
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Τhe role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma
2009
Pulmonary immune cells in health and disease: the eosinophil leucocyte (Part II)
1994
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Th2 Cells: Orchestrating Barrier Immunity
2004
Cellular sites of extrarenal and renal erythropoietin production in anaemic rats
1992
Inhibitors of cyclo-oxygenase-2 and secretory phospholipase A2 preserve bone architecture following ovariectomy in adult rats
2006
Inhibition of secretory phospholipase A. 1-Design, synthesis and structure–activity relationship studies starting from 4-tetradecyloxybenzamidine to obtain specific inhibitors of group II sPLAs
2005
Immunoregulatory functions of mTOR inhibition
2009
A potent and selective inhibitor of group IIa secretory phospholipase A2 protects rats from TNBS-induced colitis
2005
The human basophil
1990
Adenosine receptors and asthma
2008
Plasma platelet activating factor-acetylhydrolase (PAF-AH)
2003
Measurement of histamine-releasing factor activity in individual nasal washings: Relationship with atopy, basdphil response, and membrane-bound IgE
1992
CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation
2016
The proinflammatory mediator Platelet Activating Factor is an effective substrate for human group X secreted phospholipase A2
2006
IgE receptor-mediated arachidonic acid release by rat basophilic leukemia (RBL-2H3) cells: Possible role in activating degranulation
1992
24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids
1999
New Concepts about the Mast Cell
1993
A comparison of the inhibitory effect of cromoline and nedocromil Na on histamine release from airway metachromatic cells and from peripheral basophils
1996
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Transgenic Expression of Group V, but Not Group X, Secreted Phospholipase A2 in Mice Leads to Neonatal Lethality because of Lung Dysfunction
2006
Eotaxin: from an eosinophilic chemokine to a major regulator of allergic reactions
1999
Mast Cell Chemotaxis – Chemoattractants and Signaling Pathways
2012
Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma
1999
Mast cells and basophils: friends as well as foes in bronchial asthma?
2004
Bioactive products generated by Group V sPLA2 hydrolysis of LDL activate macrophages to secrete pro-inflammatory cytokines
2010
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Highlights in cardiovascular effects of histamine and HI‐receptor ansgonists
1997
Antibacterial actions of secreted phospholipases A2. Review
2008
Blockade of Human Group X Secreted Phospholipase A2 (GX-sPLA2)-induced Airway Inflammation and Hyperresponsiveness in a Mouse Asthma Model by a Selective GX-sPLA2 Inhibitor
2011
A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects
2002
Systemic Adverse Effects of Inhaled Corticosteroid Therapy
1999
Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.
1995
The development of allergic inflammation
2008 StandoutNature
The mast cell IgG receptors and their roles in tissue inflammation
2007
The relationship between RAST and skin test results in patients with asthma or rhinitis: A quantitative study with purified major allergens
1996
Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions.
1997
Secreted phospholipases A2: A proinflammatory connection between macrophages and mast cells in the human lung
2009
Mast Cell Proteases
2007
Effects of flavonoids on immune and inflammatory cell functions
1992
Mammalian platelet-activating factor acetylhydrolases
1996
Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion
2002
Production of Erythropoietin by Liver Cells in Vivo and in Vitro
1994 StandoutNobel
Secretory phospholipase A2 of group IIA: Is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?
2005
Mitochondrial metabolism promotes adaptation to proteotoxic stress
2019
The phospholipase A2 superfamily and its group numbering system
2006 Standout
Expression of high-affinity IgE receptors (FcϵRI) on peripheral blood basophils, monocytes, and eosinophils in atopic and nonatopic subjects: Relationship to total serum IgE concentrations
1997
Heterogeneity of mast cells and T cells in the nasal mucosa
1996
M-Type Phospholipase A 2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy
2009 Standout
R‐form LPS, the master key to the activation ofTLR4/MD‐2‐positive cells
2006 StandoutNobel
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Evidence for Plasticity and Structural Mimicry at the Immunoglobulin Light Chain-Protein L Interface
2002
Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A
1991 Nature
Atherosclerosis — An Inflammatory Disease
1999 Standout
The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines
2008
Mucosal immunity and allergic responses: lack of regulation and/or lack of microbial stimulation?
2005
Inflammation in atherosclerosis
2002 StandoutNature
Mast cell-mediated induction of ICAM-1, VCAM-1 and E-selectin in endothelial cells in vitro: constitutive release of inducing mediators but no effect of degranulation
1997
Origin and physiological roles of inflammation
2008 StandoutNature
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
1992 StandoutNature
Anti-inflammatory properties and inhibition of leukotriene C4 biosynthesisin vitro by flavonoid baicalein fromScutellaria baicalensis georgy roots
1993
Blockage by SP600125 of Fc Receptor-Induced Degranulation and Cytokine Gene Expression in Mast Cells is Mediated Through Inhibition of Phosphatidylinositol 3-Kinase Signalling Pathway
2008
Mast-cell responses to pathogens
2004
Histamine and tryptase in nasal lavage fluid after allergen challenge: Effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine
1999
Synovial mast cells: role in acute and chronic arthritis
2007
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
1994 StandoutNature
Atherosclerosis
2000 StandoutNature
Effect of astemizole on antigen‐mediated histamine release from the blood of patients with allergic rhinitis
1992
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
2010 StandoutNature
Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti‐rheumatic therapy
2007
Analysis of expression of secreted phospholipases A2 in mouse tissues at protein and mRNA levels
2006
The role of the basophil in allergic inflammation
1995
Risk-Benefit Assessment of Fluticasone Propionate in the Treatment of Asthma and Allergic Rhinitis
1998
Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2)
2008
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
2003 StandoutNature
Relationship between levels of secreted phospholipase A2 groups IIA and X in the airways and asthma severity
2011
Release of Free F2-isoprostanes from Esterified Phospholipids Is Catalyzed by Intracellular and Plasma Platelet-activating Factor Acetylhydrolases
2005
Epinastine, a nonsedating histamine H1 receptor antagonist, has a negligible effect on HERG channel
1999
Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy
2017
The role of T lymphocytes in the pathogenesis of asthma
2003
Bromoenol Lactone Inhibits Magnesium-dependent Phosphatidate Phosphohydrolase and Blocks Triacylglycerol Biosynthesis in Mouse P388D1 Macrophages
1996
Second-Generation Antihistamines
1999
A Neurotensin Receptor Antagonist Inhibits Acute Immobilization Stress-Induced Cardiac Mast Cell Degranulation, a Corticotropin-Releasing Hormone-Dependent Process
1998
Regulation of beta-adrenergic receptors by "permissive" hormones: glucocorticoids increase steady-state levels of receptor mRNA.
1988
Structural Aspects and Heterogeneity of Immunoglobulin Fc Receptors
1981
The Influence of Histamine on Immune and Inflammatory Responses
1984
Localization of cells producing erythropoietin in murine liver by in situ hybridization [see comments]
1991
Novel Mammalian Group XII Secreted Phospholipase A2Lacking Enzymatic Activity,
2003
The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer
2017
Modulation of the effect of histamine-releasing lymphokine on human basophils
1984
Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin.
1996 StandoutNobel
Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids.
1996
Biochemistry and Physiology of Mammalian Secreted Phospholipases A2
2008
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.
1993 StandoutNobel
Differential determination of phospholipase A2 and PAF-acetylhydrolase in biological fluids using fluorescent substrates
1999
Effects of chalcone derivatives on lipoxygenase and cyclooxygenase activities of mouse epidermis
1985
Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics
1999
Effect of short‐term treatment with fluticasone propionate nasal spray on the response to nasal allergen challenge.
1994
Renal erythropoietin: Properties and production
2006
Group X Secretory Phospholipase A 2 Negatively Regulates ABCA1 and ABCG1 Expression and Cholesterol Efflux in Macrophages
2010
Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease
1999
Cooperation Between Secretory Phospholipase A 2 and TNF-Receptor Superfamily Signaling
2002
Maitotoxin and P2Z/P2X7purinergic receptor stimulation activate a common cytolytic pore
1999
Hepatic Regeneration and Erythropoietin Production in the Rat
1977 Science
Group IB Secretory Phospholipase A2 Stimulates CXC Chemokine Ligand 8 Production via ERK and NF-κB in Human Neutrophils
2004
In Vivo Protective Role of Human Group IIA Phospholipase A2 against Experimental Anthrax
2005
Mast Cells Exert Effects Outside the Central Nervous System to Influence Experimental Allergic Encephalomyelitis Disease Course
2003
In Vitro Desensitization of Beta Adrenergic Receptors in Human Neutrophils. ATTENUATION BY CORTICOSTEROIDS
1983 StandoutNobel
Polycythemia: Mechanisms and Management
1981
Effect of Dietary Enrichment with Eicosapentaenoic and Docosahexaenoic Acids on in Vitro Neutrophil and Monocyte Leukotriene Generation and Neutrophil Function
1985 StandoutNobel
The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology.
1984
Lipoprotein-Associated and Secreted Phospholipases A 2 in Cardiovascular Disease
2010
Flavonoid inhibition of human basophil histamine release stimulated by various agents
1984
Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium
1997
Inducible operation of the erythropoietin 3' enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism.
1993 StandoutNobel
Novel Peptide Inhibitors of Human Secretory Phospholipase A2 with Antiinflammatory Activity: Solution Structure and Molecular Modeling
2007
In Silico-Guided Target Identification of a Scaffold-Focused Library: 1,3,5-Triazepan-2,6-diones as Novel Phospholipase A2 Inhibitors
2006
The regulated expression of erythropoietin by two human hepatoma cell lines.
1987
Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils
1997 StandoutNobel
Adenovirus-Mediated Gene Transfer of Human Platelet-Activating Factor–Acetylhydrolase Prevents Injury-Induced Neointima Formation and Reduces Spontaneous Atherosclerosis in Apolipoprotein E–Deficient Mice
2001
Contributions of Amino Acid Side Chains to the Kinetics and Thermodynamics of the Bivalent Binding of Protein L to Ig κ Light Chain
2004 StandoutNobel
The Yin and Yang of Oxidation in the Development of the Fatty Streak
1996 Standout
Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice.
1991 StandoutNobel
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
1996 StandoutNobel
Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium
1997
Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer.
1994 StandoutNobel
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
The mast cell and allergic diseases: role in pathogenesis and implications for therapy
2007
Resident Cardiac Mast Cells Degranulate and Release Preformed TNF-α, Initiating the Cytokine Cascade in Experimental Canine Myocardial Ischemia/Reperfusion
1998
Emerging roles of secreted phospholipase A2 enzymes: Lessons from transgenic and knockout mice
2010
Metabolic reprogramming and cancer progression
2020 StandoutScience
cAMP stimulates transcription of the beta 2-adrenergic receptor gene in response to short-term agonist exposure.
1989 StandoutNobel
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Erythropoietin Production by Fetal Mouse Liver Cells in Response to Hypoxia and Adenylate Cyclase Stimulation*
1986
Comparison of the effects of quercetin with those of other flavonoids on the generation and effector function of cytotoxic T lymphocytes
1984
Effect of flurbiprofen, a cyclooxygenase inhibiting drug, on induced allergic rhinitis
1984
Renal and Extrarenal Erythropoietin Production in Anaemic Rats
1980
Tissue-specific contributions of Tmem79 to atopic dermatitis and mast cell-mediated histaminergic itch
2018 StandoutNobel
Adenosine receptors: Clinical implications and biochemical mechanisms
1988
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene.
1991 StandoutNobel
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Polycythemia in transgenic mice expressing the human erythropoietin gene.
1989 StandoutNobel
Presentation of a Viral T Cell Epitope Expressed in the CDR3 Region of a Self Immunoglobulin Molecule
1993 StandoutScienceNobel
Transient up-regulation of P2Y2nucleotide receptor mRNA expression is an immediate early gene response in activated thymocytes
1997 StandoutNobel
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
The Nerve Growth Factor 35 Years Later
1987 StandoutScienceNobel
JNK1 controls mast cell degranulation and IL-1β production in inflammatory arthritis
2010 StandoutNobel
Atherogenic properties of LDL particles modified by human group X secreted phospholipase A2 on human endothelial cell function
2006
The effect of the immunophilin ligands rapamycin and FK506 on proliferation of mast cells and other hematopoietic cell lines.
1992
THE HIGH-AFFINITY Ig E RECEPTOR (FcεRI): From Physiology to Pathology
1999
The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors
2006
Works of Gianni Marone being referenced
Heterogeneity of human mast cells and basophils
1988
Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer
2016
Activation of human inflammatory cells by secreted phospholipases A2
2006
Modulation of histamine release from human basophils in vitro by physiological concentrations of zinc.
1981
Milestones in the biology and pharmacology of histamine H1‐receptor antagonists
1997
Molecular Basis for the Lack of HERG K+ Channel Block-Related Cardiotoxicity by the H1 Receptor Blocker Cetirizine Compared with Other Second-Generation Antihistamines
1998
Secretory phospholipases A2 in inflammatory and allergic diseases: Not just enzymes
2005
The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements
2016
Human Heart Mast Cells in Anaphylaxis and Cardiovascular Disease
1995
Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs
1997
Probing the roles of mast cells and basophils in natural and acquired immunity, physiology and disease
2002
Human Basophil/Mast Cell Releasability: V. Functional Comparisons of Cells Obtained from Peripheral Blood, Lung Parenchyma, and Bronchoalveolar Lavage in Asthmatics
1989
Tumor associated macrophages and neutrophils in tumor progression
2012
Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8–Akt–Slug pathway
2015
Control Mechanisms of Mediator Release in Human Basophils and Mast Cells
1988
Adenosine Potentiates Mediator Release from Human Lung Mast Cells
1988
Protein Fv Produced during Viral Hepatitis Is an Endogenous Immunoglobulin Superantigen Activating Human Heart Mast Cells
2003
Lung mast cells are a source of secreted phospholipases A2
2009
Pathophysiology of human basophils and mast cells in allergic disorders
1989
Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity
1999
Contrast media are incomplete secretagogues acting on human basophils and mast cells isolated from heart and lung, but not skin tissue
1996
Expression of the Chemokine Receptor CCR3 on Human Mast Cells
2001
The histamine-cytokine network in allergic inflammation
2003
Secretory Phospholipases A<sub>2</sub> as Multivalent Mediators of Inflammatory and Allergic Disorders
2003
Novel Autocrine and Paracrine Loops of the Stem Cell Factor/Chymase Network
1999
Inhibition of Histamine and Prostaglandin D<sub>2</sub> Release from Human Lung Mast Cells by Ciclosporin A
1989
Secretory phospholipases A2 induce cytokine release from blood and synovial fluid monocytes
2002
Human Heart Mast Cells: A Definitive Case of Mast Cell Heterogeneity
1995
Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterization
1996
Formyl peptide receptors at the interface of inflammation, angiogenesis and tumor growth
2015
Differentiation of monocytes into macrophages induces the upregulation of histamine H1 receptor
2006
Human Basophil Releasability: VI. Changes in Basophil Releasability in Patients with Allergic Rhinitis or Bronchial Asthma
1990
Diagnostic criteria and classification of mastocytosis: a consensus proposal
2001 Standout
Expression of phospholipases A2 in primary human lung macrophages
2008
Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.
1994
Asthma: recent advances
1998
Immunological characterization and functional importance of human heart mast cells
1995
Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human FcepsilonRI+ cells
1997
Signaling events involved in cytokine and chemokine production induced by secretory phospholipase A2 in human lung macrophages
2006
Tryptase-Chymase Double-Positive Human Mast Cells Express the Eotaxin Receptor CCR3 and Are Attracted by CCR3-Binding Chemokines
1999
IgG Anti-IgE from Atopic Dermatitis Induces Mediator Release from Basophils and Mast Cells
1989
Characterization of Platelet-activating Factor Acetylhydrolase in Human Bronchoalveolar Lavage
1997
Activation of human basophils by staphylococcal protein A. I. The role of cyclic AMP, arachidonic acid metabolites, microtubules and microfilaments.
1982
Human basophil releasability. III. Genetic control of human basophil releasability
1987
What Are Human Heart Mast Cells For?
2015
The Role of Basophils in Inflammatory Reactions
1978
Eosinophil granule proteins activate human heart mast cells.
1996
An inhibitor of lipoxygenase inhibits histamine release from human basophils
1980
Activation of Cytokine Production by Secreted Phospholipase A2 in Human Lung Macrophages Expressing the M-Type Receptor
2005
A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group
1993
Effect of activation of the H1 receptor on coronary hemodynamics in man.
1986
The role of agonists that activate adenylate cyclase in the control of cAMP metabolism and enzyme release by human polymorphonuclear leukocytes.
1980
Role of Erythrogenin from Liver and Spleen in Erythropoietin Production in the Anephric Rat
1973 Nature
Adenosine Receptors on Human Inflammatory Cells
1985
Inhibition of IgE-Mediated Histamine Release from Human Basophils and Mast Cells by Fenoterol
1984
Characterization of a Specific Adenosine Receptor on Human Lymphocytes
1978
Maitotoxin, a novel activator of mediator release from human basophils, induces large increases in cytosolic calcium resulting in histamine, but not leukotriene C4, release.
1992
Tat Protein Is an HIV-1-Encoded β-Chemokine Homolog That Promotes Migration and Up-Regulates CCR3 Expression on Human FcεRI+ Cells
2000
Differential roles for triglyceride and phospholipid pools of arachidonic acid in human lung macrophages.
1994
Mechanism of activation of human basophils by Staphylococcus aureus Cowan 1
1987
Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin
1987
Metabolism of Lipid Mediators in Human Basophils and Mast Cells
1995
Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
1992
The mechanism of basophil histamine release induced by pepstatin A.
1984
Urokinase Induces Basophil Chemotaxis through a Urokinase Receptor Epitope That Is an Endogenous Ligand for Formyl Peptide Receptor-Like 1 and -Like 2
2004
Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofin
1986
IgE‐Mediated Basophil Phenomena: Quantitation, Control, Inflammatory Interactions
1978
FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells
1991
Ciclosporin A Inhibits Mediator Release from Human FcεRI<sup>+</sup> Cells by Interacting with Cyclophilin
1991
Possible role of calmodulin in the control of histamine release from human basophil leukocytes
1986
Stem Cell Factor in Mast Cells and Increased Mast Cell Density in Idiopathic and Ischemic Cardiomyopathy
1998
Role of the hypophysis in erythropoietin production during hypoxia
1978
Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization.
1995
IgE-Mediated Histamine Release from Human Basophils: Differences between Antigen E- and Anti-IgE-Induced Secretion
1981
Secretory Phospholipases A2 Induce β-Glucuronidase Release and IL-6 Production from Human Lung Macrophages
2000
Effects of histamine on coronary hemodynamics in humans: Role of H1and H2receptors
1987
Histamine Induces Exocytosis and IL-6 Production from Human Lung Macrophages Through Interaction with H1 Receptors
2001
Bacterial Immunoglobulin Superantigen Proteins A and L Activate Human Heart Mast Cells by Interacting with Immunoglobulin E
2000
Activation of human basophils byStaphylococcus aureus Cowan I. II. Alternative F(ab′)-mediated mechanism
1985
Adenosine Receptor on Human Basophils: Modulation of Histamine Release
1979
Inhibition of histamine release from human basophils in vitro by calmodulin antagonists
1983
The Human Heart As a Shock Organ in Anaphylaxis
2004
Human basophil releasability
1986
Occurrence and significance of tumor‐associated neutrophils in patients with colorectal cancer
2016
Increased erythropoietin production in anephric rats with hyperplasia of the reticuloendothelial system induced by colloidal carbon or zymosan
1976
Loratadine and desethoxylcarbonyl‐loratadine inhibit the immunological release of mediators from human FcɛRI+cells
1997
Cardiovascular Effects of Histamine Infusion in Man
1983
Secretory Phospholipases A2 Activate Selective Functions in Human Eosinophils
2003
Immunoglobulin Superantigen Protein L Induces IL-4 and IL-13 Secretion from Human FcεRI+ Cells Through Interaction with the κ Light Chains of IgE
2003
Human Basophil Releasability. II. Changes in Basophil Releasability in Patients with Atopic Dermatitis
1986
Characterization of the anti-inflammatory effect of FK-506 on human mast cells
1991
Basophils Infiltrate Human Gastric Mucosa at Sites of Helicobacter pylori Infection, and Exhibit Chemotaxis in Response to H. pylori-derived Peptide Hp(2–20)
2004
In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils.
1993
Hydrocortisone and human lymphocytes: increases in cyclic adenosine 3':5'-monophosphate and potentiation of adenylate cyclase-activating agents.
1980
Evidence for an adenosine A2/Ra receptor on human basophils
1985
HIV-1 Envelope gp41 Peptides Promote Migration of Human FcεRI+ Cells and Inhibit IL-13 Synthesis Through Interaction with Formyl Peptide Receptors
2002
Effects of Arachidonic Acid and Its Metabolites on Antigen-Induced Histamine Release from Human Basophils in Vitro
1979
Hepatic Erythropoietin: Enhanced Production in Anephric Rats with Hyperplasia of Kupffer Cells
1976
Renal Mechanisms Underlying Cyclic AMP Action on Erythropoiesis
1973
Control mechanisms of human basophil releasability
1986
Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool.
1995
Erythropoietin production by the liver in fetal-neonatal life
1975
Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin.
1990
Activation of Human Basophils by Bacterial Products
1985
Stem Cell Factor Is Localized in, Released from, and Cleaved by Human Mast Cells
1999
Control Mechanisms of Histamine Release from Human Basophils in vitro: The Role of Phospholipase A<sub>2</sub> and of Lipoxygenase Metabolites
1981
HIV-1 gp120 Induces IL-4 and IL-13 Release from Human FcεRI+ Cells Through Interaction with the VH3 Region of IgE
2000
Erythropoietin production in the rat: additive role of kidney and liver
1976